Zeria Pharmaceutical Co., Ltd. (TYO:4559)

Japan · Delayed Price · Currency is JPY

2,235.00

+43.00 (1.96%)

At close: Mar 27, 2026

Revenue by Segment

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Unallocated Adjustment	-546.56M	-610.23M	-508.12M	-558.57M	-642.66M
Ethical Pharmaceutical Business	58.98B	49.59B	43.15B	37.01B	30.02B
Ethical Pharmaceutical Business Growth	18.95%	14.92%	16.60%	23.26%	-5.49%
Consumer Health Care Business	28.18B	26.00B	25.09B	22.37B	25.26B
Consumer Health Care Business Growth	8.39%	3.64%	12.14%	-11.45%	-11.37%
Others	698.18M	751.17M	657.42M	715.07M	799.69M
Others Growth	-7.05%	14.26%	-8.06%	-10.58%	10.36%
Total	87.31B	75.73B	68.38B	59.53B	55.44B
Total Growth	15.30%	10.74%	14.87%	7.38%	-8.25%

Revenue by Geography

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Europe	-	24.41B	20.15B	20.95B	15.11B
Europe Growth	-	21.11%	-3.82%	38.64%	8.43%
Japan	37.60B	36.75B	36.00B	34.86B	36.35B
Japan Growth	2.32%	2.09%	3.26%	-4.08%	-12.78%
Other	5.96B	5.03B	4.90B	3.71B	3.98B
Other Growth	18.60%	2.53%	31.95%	-6.72%	-17.30%
UK	11.35B	9.54B	7.33B	-	-
UK Growth	18.97%	30.19%	-	-	-
France	9.05B	-	-	-	-
Other Europe	23.35B	-	-	-	-
Total	87.31B	75.73B	68.38B	59.53B	55.44B
Total Growth	15.30%	10.74%	14.87%	7.38%	-8.25%

Source: S&P Global Market Intelligence.